CHAC1 and breast carcinoma: Interestingly, ChaC1 was suggested as a novel biomarker because the overexpression of mammalian ChaC1 and its related transcript variants has been previously found to promote cell proliferation in breast cancer cell lines Hs578T and BT-20 [18,47,48].